Group 1 - Addex Therapeutics Ltd. Sponsored ADR (ADXN) has returned 86.9% year-to-date, significantly outperforming the average return of 10.1% for the Medical sector [2][3] - The Zacks Consensus Estimate for ADXN's full-year earnings has increased by 97% over the past 90 days, indicating stronger analyst sentiment and an improving earnings outlook [2] - Addex Therapeutics is ranked 2 (Buy) in the Zacks Rank system, which focuses on earnings estimates and revisions [1][2] Group 2 - Addex Therapeutics is part of the Medical - Drugs industry, which consists of 180 companies and currently ranks 99 in the Zacks Industry Rank, with the industry having lost about 2.3% year-to-date [3] - Boston Scientific (BSX), another outperforming Medical stock, has returned 40.8% year-to-date and belongs to the Medical - Products industry, which has moved up by 12.5% this year [2][3] - The Medical sector overall is ranked 4 in the Zacks Sector Rank, which evaluates the strength of individual sector groups [1]
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year?